Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Gross

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Drug, Healthcare and Patient Safety|March 26, 2013
Safety and tolerability of inhalational anticholinergics in COPDAmir Sharafkhaneh, Hashir Majid, Nicholas J Gross
American Health & Drug Benefits|July 4, 2014
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the TrendChristopher M Blanchette, Nicholas J Gross, Pablo Altman
COPD|April 20, 2010
Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitorNicholas J Gross, Mark A Giembycz, Stephen I Rennard
Clinical Therapeutics|November 29, 2007
Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trialHarold S Nelson, Nicholas J Gross, Bernard Levine, et al.
Respiratory Medicine|March 26, 2008
Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patientsNicholas J Gross, Harold S Nelson, Robert J Lapidus, et al.
Pulmonary Pharmacology & Therapeutics|July 29, 2008
Nebulized formoterol fumarate: Dose selection and pharmacokineticsNicholas J Gross, Edward Kerwin, Bernard Levine, et al.
Respiratory Research|April 27, 2011
Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary diseasePaul W Jones, Stephen I Rennard, Alvar Agusti, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Drug, Healthcare and Patient Safety|March 26, 2013
Safety and tolerability of inhalational anticholinergics in COPDAmir Sharafkhaneh, Hashir Majid, Nicholas J Gross
American Health & Drug Benefits|July 4, 2014
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the TrendChristopher M Blanchette, Nicholas J Gross, Pablo Altman
COPD|April 20, 2010
Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitorNicholas J Gross, Mark A Giembycz, Stephen I Rennard
Clinical Therapeutics|November 29, 2007
Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trialHarold S Nelson, Nicholas J Gross, Bernard Levine, et al.
Respiratory Medicine|March 26, 2008
Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patientsNicholas J Gross, Harold S Nelson, Robert J Lapidus, et al.
Pulmonary Pharmacology & Therapeutics|July 29, 2008
Nebulized formoterol fumarate: Dose selection and pharmacokineticsNicholas J Gross, Edward Kerwin, Bernard Levine, et al.
Respiratory Research|April 27, 2011
Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary diseasePaul W Jones, Stephen I Rennard, Alvar Agusti, et al.
Pageof 4